Purchase this article with an account.
Rishi P. Singh, Anirudh Paspulati, Sofia Theodoropoulou; Triamcinolone as an Adjuvant to Reduce Post-operative Epiretinal Membrane Peel Edema- A Pilot Study. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4494.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the clinical outcome and complications of post-operative intravitreal injections of triamcinolone acetonide (TA) in patients undergoing pars plana vitrectomy with peeling for the treatment of idiopathic epiretinal membrane.
This retrospective comparative study included 22 patients (22 eyes) who underwent pars plana vitrectomy with membrane peeling for the treatment of idiopathic epiretinal membrane. 15 eyes (15 patients) received an intravitreal injection of 4mg (0.1 cc) of triamcinolone acetonide at the end of surgery, and no injection was done for 7 eyes (7 patients). Main outcome measures were visual acuity (VA) and intraocular pressure (IOP). Minimum follow-up was 3 months.
Twenty-two eyes of 22 patients were included in the study. The follow-up ranged from 3 to 12 months. Visual acuity three months after operation was improved in both group of patients receiving intravitreal injection of TA and control group (p0.05).
The present pilot study suggests that postoperative intravitreal injection of triamcinolone acetonide does not lead to better visual outcomes in patients undergoing pars plana vitrectomy for the treatment of idiopathic epiretinal membranes.
This PDF is available to Subscribers Only